PAX6 and central nervous system cancer: Our earlier work confirmed that PAX6 expression is reduced in gliomas tissues and that its overexpression inhibits glioma cell proliferation and invasion [17]; however, the molecular mechanism by which PAX6 regulates malignant phenotypes in the glioma microenvironment has not been fully elucidated, as PAX6 exhibits functional heterogeneity across different tumor types.